This is the authors' abstract. We don't add key points for this paper.
We present a highly efficient method for cyanating challenging substrates with a specific focus on aryl fluorides. This innovative methodology has been successfully expanded to encompass a diverse array of aryl halides, underscoring its versatility and broad applicability. The nickel-catalyzed protocol utilizes acetonitrile under mild temperature conditions, providing a clean and safe alternative for cyanation. Notably, it employs a nonhazardous, nongaseous, metal-free cyanide source and demonstrates a wide substrate scope, accommodating aryl chlorides, fluorides, bromides, and iodides. The reaction is particularly effective with acetonitrile. This catalytic cyanation process serves as a valuable route for synthesizing pharmaceuticals such as letrozole, citalopram, and other NNRTI drugs. Mechanistically, we propose that a catalytic cycle involving zerovalent nickel and divalent nickel is more plausible for this reaction.
No takes yet. Share an insight, caveat, or question.
Siddique et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: